Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.

Ho KY, Yeh TS, Huang HH, Hung KF, Chai CY, Chen WT, Tsai SM, Chang NC, Chien CY, Wang HM, Wu YJ.

Int J Mol Sci. 2013 Jul 11;14(7):14439-59. doi: 10.3390/ijms140714439.

2.

Heat shock proteins in middle ear cholesteatoma.

Shinoda H, Huang CC.

Otolaryngol Head Neck Surg. 1996 Jan;114(1):77-83.

PMID:
8570255
3.

Cholesteatoma growth and proliferation: relevance with serpin B3.

Ho KY, Huang HH, Hung KF, Chen JC, Chai CY, Chen WT, Tsai SM, Chien CY, Wang HM, Wu YJ.

Laryngoscope. 2012 Dec;122(12):2818-23. doi: 10.1002/lary.23547.

PMID:
23239141
4.

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.

J Mol Med (Berl). 2015 Mar;93(3):305-14. doi: 10.1007/s00109-014-1217-3. Epub 2014 Nov 12.

5.

Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.

Lim SO, Park SG, Yoo JH, Park YM, Kim HJ, Jang KT, Cho JW, Yoo BC, Jung GH, Park CK.

World J Gastroenterol. 2005 Apr 14;11(14):2072-9.

6.
7.

Overexpression of ErbB-2 protein in human middle ear cholesteatomas.

Sakamoto T, Kondo K, Yamasoba T, Suzuki M, Sugasawa M, Kaga K.

Laryngoscope. 2004 Nov;114(11):1988-91.

PMID:
15510028
8.

Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.

Slotta-Huspenina J, Berg D, Bauer K, Wolff C, Malinowsky K, Bauer L, Drecoll E, Bettstetter M, Feith M, Walch A, Höfler H, Becker KF, Langer R.

PLoS One. 2012;7(7):e41420. doi: 10.1371/journal.pone.0041420. Epub 2012 Jul 24.

9.

Proteomic analysis of cholesteatoma.

Kim JL, Jung HH.

Acta Otolaryngol. 2004 Sep;124(7):783-8.

PMID:
15370560
10.

Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus.

Langer R, Feith M, Siewert JR, Wester HJ, Hoefler H.

BMC Cancer. 2008 Mar 10;8:70. doi: 10.1186/1471-2407-8-70.

11.

Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.

Choung YH, Park K, Kang SO, Markov Raynov A, Ho Kim C, Choung PH.

Acta Otolaryngol. 2006 Feb;126(2):138-43.

PMID:
16428189
12.

Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.

Tanaka Y, Kojima H, Miyazaki H, Koga T, Moriyama H.

Laryngoscope. 1999 Jul;109(7 Pt 1):1102-7.

PMID:
10401849
13.

Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.

Liu W, Yin T, Ren J, Li L, Xiao Z, Chen X, Xie D.

Eur Arch Otorhinolaryngol. 2014 Feb;271(2):265-73. doi: 10.1007/s00405-013-2403-6. Epub 2013 Mar 5.

PMID:
23463347
14.

Increased expression of p63 and survivin in cholesteatomas.

Park HR, Min SK, Min K, Jun SY, Seo J, Kim HJ.

Acta Otolaryngol. 2009 Mar;129(3):268-72. doi: 10.1080/00016480802251591.

PMID:
18615329
15.

Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.

Woo HJ, Park JC, Bae CH, Song SY, Lee HM, Kim YD.

Acta Otolaryngol. 2009 Jun;129(6):624-9. doi: 10.1080/00016480802342457.

PMID:
18720059
17.

Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.

Huisman MA, De Heer E, Grote JJ.

Otol Neurotol. 2006 Apr;27(3):422-6.

PMID:
16639284
18.

Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.

Lee DW, Chung JH, Lee SH, Park CW, Kang SH, Oh YH, Pyo JY.

Eur Arch Otorhinolaryngol. 2016 Apr;273(4):845-51. doi: 10.1007/s00405-015-3621-x. Epub 2015 Apr 12.

PMID:
25864182
19.

Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.

Huang CC, Chen CT, Huang TS, Shinoda H.

Eur Arch Otorhinolaryngol. 1996;253(7):385-9.

PMID:
8891480
20.

[Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].

Liu D, Ma X.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Feb;28(4):238-42, 245. Chinese.

PMID:
24800539

Supplemental Content

Support Center